BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Vycor Medical Inc. Completes Equity Offering

  April 28, 2014

   · 

  6 min read
• Biotage AB Launches Share Buy-Back

  April 28, 2014

   · 

  1 min read
• Pharm Country

  Athena Diagnostics To Present Original Research On Neurogenetics At American Academy of Neurology’s 2014 Annual Meeting

  April 28, 2014

   · 

  4 min read
• Business

  PDI, Inc. To Hold First Quarter Financial Results Conference Call On Thursday, May 8, 2014

  April 28, 2014

   · 

  1 min read
• FDA

  BioMarin Pharmaceutical Inc. Announces European Commission Approval For VIMIZIM® (Elosulfase Alfa) For The Treatment Of Morquio A Syndrome In Patients Of All Ages

  April 28, 2014

   · 

  1 min read
• Drug Development

  Phase I Clinical Study Of Neumedicines Inc.’ Interleukin-12 As A Treatment For Wound Healing And Infections Recommended For Funding By The U.S. Department Of Defense

  April 28, 2014

   · 

  1 min read
• Drug Development

  Genervon Successfully Completes Its Phase 2a Clinical Trial For ALS

  April 28, 2014

   · 

  1 min read
• Bio NC

  Monarch Medical Launches New EndoTool IV™ To Further Enhance Patient-Specific Glycemic Control In Hospitals

  April 28, 2014

   · 

  1 min read
• Biotech Beach

  Verdezyne, Inc. Nabs $48 Million Financing

  April 28, 2014

   · 

  3 min read
• Drug Development

  Synergy Pharmaceuticals Initiates Second Phase 3 Clinical Trial Of Plecanatide In Patients With Chronic Idiopathic Constipation

  April 28, 2014

   · 

  1 min read